Lantern Pharma Inc (LTRN)
5.34
+0.01
(+0.19%)
USD |
NASDAQ |
May 02, 16:00
5.34
0.00 (0.00%)
After-Hours: 20:00
Lantern Pharma Free Cash Flow (Quarterly): -3.390M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.390M |
| September 30, 2023 | -3.617M |
| June 30, 2023 | -3.592M |
| March 31, 2023 | -3.766M |
| December 31, 2022 | -2.676M |
| September 30, 2022 | -4.045M |
| June 30, 2022 | -2.747M |
| March 31, 2022 | -3.328M |
| December 31, 2021 | -2.039M |
| September 30, 2021 | -4.686M |
| Date | Value |
|---|---|
| June 30, 2021 | -1.738M |
| March 31, 2021 | -2.144M |
| December 31, 2020 | -1.573M |
| September 30, 2020 | -2.893M |
| June 30, 2020 | -0.4987M |
| March 31, 2020 | -0.703M |
| December 31, 2019 | -0.7089M |
| September 30, 2019 | -0.5556M |
| June 30, 2019 | -0.4435M |
| March 31, 2019 | -0.4256M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.686M
Minimum
Sep 2021
-0.4435M
Maximum
Jun 2019
-2.376M
Average
-2.676M
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| Eyenovia Inc | -6.467M |
| Cassava Sciences Inc | -22.36M |
| Alpine Immune Sciences Inc | -19.08M |
| Clearside Biomedical Inc | 0.375M |
| Poseida Therapeutics Inc | -29.05M |